Treatment of Bowen's disease with photodynamic therapy. Observational study in 171 patients with 5-aminolaevulinic acid (BF-200 ALA) and methyl aminolaevulinate (MAL)

被引：10
|
作者：
Alique-Garcia, Sergio [1 ,2 ]
Alique, Daniel [3 ]
Company-Quiroga, Jaime [1 ]
Sanchez, Alberto [2 ,4 ]
Hernandez Nunez, Almudena [1 ]
Borbujo, J. [1 ]
机构：
[1] Hosp Univ Fuenlabrada, Dept Dermatol, C Camino Molino 2, Madrid 28942, Spain
[2] Univ Rey Juan Carlos, Madrid, Spain
[3] Univ Politecn Madrid, Sch Agr Food & Biosyst Engn, Madrid, Spain
[4] Res Ctr Computat Simulat, Madrid, Spain
来源：
PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY | 2019年 / 28卷
关键词：
Bowen's disease; Photodynamic therapy; 5-aminolaevulinic acid; Methyl aminolaevulinate; SQUAMOUS-CELL CARCINOMA; SKIN;
D O I：
10.1016/j.pdpdt.2019.08.011
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
An observational study was carried out in the photodynamic therapy (PDT) section of Fuenlabrada's hospital (Madrid, Spain). Our goal was to investigate the efficacy and safety of PDT in Bowen's disease (BD). Between June 2011-June 2017 171 patients (191 lesions) with diagnosis of BD were enrolled in the study (95 women and 76 men; average age of 74.31 years). Lesions were treated with one 5-aminolaevulinic acid (BF-200 ALA)-PDT or methyl-5-aminolaevulinate (MAL)-PDT cycle of two sessions in one week. A second treatment cycle was performed in cases of clinical persistence at 12 weeks. Our results showed that 47/55 lesions were resolved (84.75%) after one or two ALA-PDT cycle and 75/136 lesions (55.15%) after one or two MAL-PDT cycles, in the 12-month follow-up. In conclusion PDT is a safe and non-invasive treatment option in BD. In addition, our results suggest a better response with ALA-PDT over MAL-PDT. Limits: observational study with a limited number of patients.
引用
收藏
页码：192 / 194
页数：3
相关论文
共 50 条
  • [21] A COMPARATIVE STUDY BETWEEN 5-AMINOLAEVULINIC ACID AND METHYL AMINOLEVULINATE PHOTODYNAMIC THERAPY: ASSESSMENT OF FLUORESCENCE, PAIN AND EFFICACY
    Valentine, Ronan
    Ibbotson, Sally
    Brown, Tom
    Wood, Kenny
    Moseley, Harry
    LASERS IN SURGERY AND MEDICINE, 2010, : 7 - 7
  • [22] Investigation of the use of the pulsed dye laser in the treatment of Bowen's disease using 5-aminolaevulinic acid phototherapy
    Britton, JER
    Goulden, V
    Stables, G
    Stringer, M
    Sheehan-Dare, R
    BRITISH JOURNAL OF DERMATOLOGY, 2005, 153 (04) : 780 - 784
  • [23] Long-term (6 and 12 months) follow-up of two prospective, randomized, controlled phase III trials of photodynamic therapy with BF-200 ALA and methyl aminolaevulinate for the treatment of actinic keratosis
    Dirschka, T.
    Radny, P.
    Dominicus, R.
    Mensing, H.
    Bruening, H.
    Jenne, L.
    Karl, L.
    Sebastian, M.
    Oster-Schmidt, C.
    Kloevekorn, W.
    Reinhold, U.
    Tanner, M.
    Groene, D.
    Deichmann, M.
    Simon, M.
    Huebinger, F.
    Hofbauer, G.
    Kraehn-Senftleben, G.
    Borrosch, F.
    Reich, K.
    Berking, C.
    Wolf, P.
    Lehmann, P.
    Moers-Carpi, M.
    Hoenigsmann, H.
    Wernicke-Panten, K.
    Hahn, S.
    Pabst, G.
    Voss, D.
    Foguet, M.
    Schmitz, B.
    Luebbert, H.
    Szeimies, R. -M.
    BRITISH JOURNAL OF DERMATOLOGY, 2013, 168 (04) : 825 - 836
  • [24] Assessment of 5-Aminolaevulinic Acid Photodynamic Therapy (ALA-PDT) in Chinese patients with actinic keratosis: Correlation of dermoscopic features with histopathology
    Jin, Qiuzi
    Li, Weiwei
    Wu, Wenting
    Zhang, Hua
    Zhao, Fang
    Zhang, Qian
    Zhang, Chunlei
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2020, 61 (03) : E339 - E343
  • [25] 5-Aminolaevulinic acid-based photodynamic therapy for actinic keratosis in Chinese patients: A prospective multicenter study
    Ran, Menglong
    Wu, Wenyu
    Tang, Yang
    Zhang, Liang
    Wan, Miaojian
    Xue, Siliang
    Zhang, Jianglin
    Li, Hang
    CHINESE MEDICAL JOURNAL, 2024, 137 (12) : 1510 - 1512
  • [26] 5-Aminolaevulinic acid-based photodynamic therapy for actinic keratosis in Chinese patients: A prospective multicenter study
    Ran Menglong
    Wu Wenyu
    Tang Yang
    Zhang Liang
    Wan Miaojian
    Xue Siliang
    Zhang Jianglin
    Li Hang
    中华医学杂志英文版, 2024, 137 (12)
  • [27] A placebo-controlled multicentre study comparing photodynamic therapy using methyl aminolaevulinate with cryotherapy and 5-fluorouracil in Bowen's disease
    Morton, CA
    Horn, M
    Leman, J
    Tack, B
    Bedane, C
    Tijioe, M
    Ibbotson, S
    Khemis, D
    Wolf, P
    BRITISH JOURNAL OF DERMATOLOGY, 2004, 151 : 2 - 2
  • [28] 5-aminolaevulinic acid nanoemulsion is more effective than methyl-5-aminolaevulinate in daylight photodynamic therapy for actinic keratosis: a nonsponsored randomized double-blind multicentre trial
    Rasanen, J. E.
    Neittaanmaki, N.
    Ylitalo, L.
    Hagman, J.
    Rissanen, P.
    Ylianttila, L.
    Salmivuori, M.
    Snellman, E.
    Gronroos, M.
    BRITISH JOURNAL OF DERMATOLOGY, 2019, 181 (02) : 265 - 274
  • [29] Methyl aminolevulinate-based photodynamic therapy of Bowen's disease: Observational study of 21 lesions
    Gomez, Clara
    Cobos, Marian
    Alberdi, Enrique
    PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY, 2019, 26 : 295 - 299
  • [30] Treatment of superficial basal cell carcinoma by topical photodynamic therapy with fractionated 5-aminolaevulinic acid 20% vs. two-stage topical methyl aminolaevulinate: results of a randomized controlled trial
    Kessels, J. P. H. M.
    Kreukels, H.
    Nelemans, P. J.
    Roozeboom, M. H.
    van Pelt, H.
    Mosterd, K.
    de Haas, E. R. M.
    Kelleners-Smeets, N. W. J.
    BRITISH JOURNAL OF DERMATOLOGY, 2018, 178 (05) : 1056 - 1063
12345